K

Kuros Biosciences
KURN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
CHF970.79M
EV
CHF954.14M
Shares Outstanding
40.95M
Beta
0.69

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
CHF31.00
P/E 2025E
-
P/Revenue 2025E
7.98x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Kuros Biosciences AG

gainify

K

Kuros Biosciences AG

KURN

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. Th...

Sector

Healthcare

Industry

Biotechnology

CEO

Fair, Christopher

Employees

158

IPO Date

2002-10-29

Headquarters

Wagistrasse 25, Schlieren, Zurich, 8952, Switzerland

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.